We are excited to share that our CytoProcessor® software has been mentioned in a research paper written by Mariana T. Rezende, Ph.D., Andrea G. C. Bianchi, and Cláudia M. Carneiro.
The publication focuses on automating cervical cancer screening through Pap tests, which involves examining cell samples from the cervix for signs of cancer.
The paper sheds light on how automation, powered by machine learning and artificial intelligence, can significantly improve the accuracy and efficiency of cervical cancer screening.
By analyzing images of cell samples, healthcare professionals can detect abnormalities more effectively and intervene earlier.
We are delighted that the efficacy of our CytoProcessor® software has been acknowledged in this article. We extend our heartfelt gratitude to the authors for their mention. Click the link above to read the research paper and learn more about the future of cervical cancer screening.
CytoProcessor® is a CE marked IVDs. The device is intended for use by healthcare professionals only. Please refer to the conditions of use recommended by the manufacturer DATEXIM by consulting the user guide.